Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

The Hydroponics Company brings immediate cash flow to Spotlight CEO Sessions

Find out more from Andrew Beehag at Proactive's CEO Sessions.

The Hydroponics Company (ASX:THC) made a barnstorming debut on the ASX last week, with the shares trading at close to double the IPO entry point of $0.20 per share.

The IPO raised $8 million, and was three times oversubscribed.

THC will generate immediate cash flow through its equipment division - a proven, long-term, profitable business with over 600 products and strong distribution networks in the U.S, Canada, U.K. and Europe.

Funds will be used to expand THC’s market share as a key manufacturer and distributor of hydroponics equipment, materials and related services.

Find out more from Andrew Beehag at Proactive's CEO Sessions.

Click below to register by email

- Melbourne: Tuesday 16th May.

- Sydney: Wednesday 17th May.

- Email Pauline here.

- Call office on (02) 9280 0700.

Presenter list

- Paradigm Biopharmaceuticals (ASX:PAR): CEO Paul Rennie

- Stonewall Resources (ASX:SWJ): MD Robert Thomson

- White Rock Minerals (ASX:WRM): MD Matthew Gill

- The Hydroponics Company (ASX:THC): CEO (medicinal Cannabis division, Canndeo) Andrew Beehag

More companies to be added to the roster...

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK